The lifetime cost of Type 2 diabetes in the United States is $283,000, making the U.S. the most expensive nation to live with the disease, according to research conducted by the University of East Anglia.
The research, led by Till Seuring, found that in high-income countries, like the U.S., the cost burden mainly falls on government or health insurance budgets.
But in low- and middle-income countries, a large part of the burden falls on the person with diabetes and their family due to very limited health insurance coverage, Seuring said. And two-thirds of new Type 2 diabetes cases are being reported in middle-income countries — such as Mexico, India, China and Egypt.
The UEA research was published in PharmacoEconomics, drawing on 109 studies assessing the economic effects of Type 2 diabetes around the world. Medical News Today reported on the study.
Our findings underline the fact that diabetes not only has strong adverse effects on people’s health but also presents a large – and at least partly avoidable – economic burden.
For both rich and poor countries, the results mean that better prevention and management of diabetes has the potential to not only bring good health but also economic gains.